These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6248279)

  • 21. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology of cytomegalovirus: immunosuppressive effects during infections.
    Ho M
    Birth Defects Orig Artic Ser; 1984; 20(1):131-47. PubMed ID: 6203569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
    Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interaction.
    Vendrell JP; Segondy M; Fournier AM; Huguet MF; Reynes J; Ducos J; Serre A
    J Infect Dis; 1991 Jul; 164(1):1-7. PubMed ID: 1647420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants.
    Aubert G; Hassan-Walker AF; Madrigal JA; Emery VC; Morte C; Grace S; Koh MB; Potter M; Prentice HG; Dodi IA; Travers PJ
    J Infect Dis; 2001 Oct; 184(8):955-63. PubMed ID: 11574909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.
    Gratama JW; Fibbe WE; Naipal AM; Slats J; Stijnen T; D'Amaro J; Bolhuis RL; The TH; Janssen J
    Bone Marrow Transplant; 1986 Dec; 1(2):141-6. PubMed ID: 2844332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus-specific humoral and cellular immune responses in human pregnancy.
    Gehrz RC; Christianson WR; Linner KM; Conroy MM; McCue SA; Balfour HH
    J Infect Dis; 1981 Mar; 143(3):391-5. PubMed ID: 6262413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection.
    Gold D; Ashley R; Handsfield HH; Verdon M; Leach L; Mills J; Drew L; Corey L
    J Infect Dis; 1988 Feb; 157(2):319-26. PubMed ID: 2826612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between cytomegalovirus and toxoplasma gondii serology and lymphocyte phenotypes in peripheral blood and cord blood.
    Gratama JW; Fridell E; Lenkei R; Oosterveer MA; Ljungström I; Tanke HJ; Linde A
    Scand J Infect Dis; 1989; 21(6):611-6. PubMed ID: 2482535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency.
    Tamura T; Chiba S; Abo W; Chiba Y; Nakao T
    Infect Immun; 1980 Apr; 28(1):49-53. PubMed ID: 6155348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infections in adult T-cell leukemia patients.
    Eizuru Y; Tamura K; Minamishima Y; Ogata K; Tada S; Inoue S; Takeshita M; Kikuchi M
    J Med Virol; 1987 Oct; 23(2):123-33. PubMed ID: 2890705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A serological study of cytomegalovirus infection at Lucknow.
    Mathur A; Jindal I; Chaturvedi UC
    Indian J Med Res; 1981 May; 73():678-81. PubMed ID: 6266952
    [No Abstract]   [Full Text] [Related]  

  • 39. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system.
    Alonso Arias R; Moro-García MA; Echeverría A; Solano-Jaurrieta JJ; Suárez-García FM; López-Larrea C
    J Virol; 2013 Apr; 87(8):4486-95. PubMed ID: 23388717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of CMV upon immune aging: facts and fiction.
    Jergović M; Contreras NA; Nikolich-Žugich J
    Med Microbiol Immunol; 2019 Aug; 208(3-4):263-269. PubMed ID: 31004198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.